z-logo
open-access-imgOpen Access
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
Author(s) -
Adriana Cordova,
Francesca Toia,
Carmela La Mendola,
Valentina Orlando,
Serena Meraviglia,
Gaetana Rinaldi,
Matilde Todaro,
Giuseppe Cicero,
Leonardo Zichichi,
Paolo Li Donni,
Nadia Caccamo,
Giorgio Stassi,
Francesco Dieli,
Francesco Moschella
Publication year - 2012
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0049878
Subject(s) - cytotoxic t cell , melanoma , tumor infiltrating lymphocytes , immunosurveillance , immunology , cancer research , immune system , interleukin 21 , biology , t cell , immunotherapy , in vitro , biochemistry
T lymphocytes are often induced naturally in melanoma patients and infiltrate tumors. Given that γδ T cells mediate antigen-specific killing of tumor cells, we studied the representation and the in vitro cytokine production and cytotoxic activity of tumor infiltrating γδ T cells from 74 patients with primary melanoma. We found that γδ T cells represent the major lymphocyte population infiltrating melanoma, and both Vδ1 + and Vδ2 + cells are involved. The majority of melanoma-infiltrating γδ cells showed effector memory and terminally-differentiated phenotypes and, accordingly, polyclonal γδ T cell lines obtained from tumor-infiltrating immune cells produced IFN-γ and TNF-α and were capable of killing melanoma cell lines in vitro . The cytotoxic capability of Vδ2 cell lines was further improved by pre-treatment of tumor target cells with zoledronate. Moreover, higher rate of γδ T cells isolation and percentages of Vδ2 cells correlate with early stage of development of melanoma and absence of metastasis. Altogether, our results suggest that a natural immune response mediated by γδ T lymphocytes may contribute to the immunosurveillance of melanoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom